NASDAQ: BCPC
Balchem Corp Stock

$160.23-1.98 (-1.22%)
Updated Jan 24, 2025
BCPC Price
$160.23
Fair Value Price
$152.91
Market Cap
$5.21B
52 Week Low
$137.69
52 Week High
$186.03
P/E
42.5x
P/B
4.42x
P/S
6.06x
PEG
2.26x
Dividend Yield
N/A
Revenue
$942.38M
Earnings
$121.54M
Gross Margin
34.5%
Operating Margin
18.49%
Profit Margin
12.9%
Debt to Equity
0.36
Operating Cash Flow
$197M
Beta
0.83
Next Earnings
Feb 14, 2025
Ex-Dividend
N/A
Next Dividend
N/A

BCPC Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine BCPC's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
C
Sentiment
A
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Chemical

Industry Rating
B
BCPC
Ranked
#13 of 53

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$9.92A
$497.22A
$42.71A
View Top Specialty Chemical Stocks

Be the first to know about important BCPC news, forecast changes, insider trades & much more!

BCPC News

Overview

Due Diligence Score

–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BCPC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BCPC ($160.23) is overvalued by 4.79% relative to our estimate of its Fair Value price of $152.91 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BCPC ($160.23) is not significantly undervalued (4.79%) relative to our estimate of its Fair Value price of $152.91 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BCPC ($160.23) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more BCPC due diligence checks available for Premium users.

Valuation

BCPC fair value

Fair Value of BCPC stock based on Discounted Cash Flow (DCF)

Price
$160.23
Fair Value
$152.91
Overvalued by
4.79%
BCPC ($160.23) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BCPC ($160.23) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BCPC ($160.23) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BCPC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
42.5x
Industry
29.84x
Market
30.33x
BCPC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BCPC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

BCPC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.42x
Industry
3.32x
BCPC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BCPC price to earnings growth (PEG)

For valuing profitable companies with growth potential

BCPC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

BCPC's financial health

Profit margin

Revenue
$239.9M
Net Income
$33.8M
Profit Margin
14.1%
BCPC's Earnings (EBIT) of $174.24M... subscribe to Premium to read more.
Interest Coverage Financials
BCPC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.6B
Liabilities
$419.7M
Debt to equity
0.36
BCPC's short-term assets ($325.99M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BCPC's short-term assets ($325.99M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BCPC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BCPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$51.3M
Investing
-$9.2M
Financing
-$34.4M
BCPC's operating cash flow ($197.09M)... subscribe to Premium to read more.
Debt Coverage Financials

BCPC vs Specialty Chemical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
BCPCB$5.21B-1.22%42.50x4.42x
CBTB$4.80B-1.23%13.01x3.37x
NEUA$4.77B-0.09%11.04x3.50x
ALTM–$6.18B+0.35%N/A0.98x
ESIB$6.32B-0.42%23.50x2.59x

Balchem Stock FAQ

What is Balchem's quote symbol?

(NASDAQ: BCPC) Balchem trades on the NASDAQ under the ticker symbol BCPC. Balchem stock quotes can also be displayed as NASDAQ: BCPC.

If you're new to stock investing, here's how to buy Balchem stock.

What is the 52 week high and low for Balchem (NASDAQ: BCPC)?

(NASDAQ: BCPC) Balchem's 52-week high was $186.03, and its 52-week low was $137.69. It is currently -13.87% from its 52-week high and 16.37% from its 52-week low.

How much is Balchem stock worth today?

(NASDAQ: BCPC) Balchem currently has 32,507,716 outstanding shares. With Balchem stock trading at $160.23 per share, the total value of Balchem stock (market capitalization) is $5.21B.

Balchem stock was originally listed at a price of $2.32 in Dec 31, 1997. If you had invested in Balchem stock at $2.32, your return over the last 27 years would have been 6,800.52%, for an annualized return of 16.98% (not including any dividends or dividend reinvestments).

How much is Balchem's stock price per share?

(NASDAQ: BCPC) Balchem stock price per share is $160.23 today (as of Jan 24, 2025).

What is Balchem's Market Cap?

(NASDAQ: BCPC) Balchem's market cap is $5.21B, as of Jan 25, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Balchem's market cap is calculated by multiplying BCPC's current stock price of $160.23 by BCPC's total outstanding shares of 32,507,716.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.